Monday, 30 September 2024 03:10 PM
September 26, 2024 08:40 am
Currently, treatment remains supportive and no effective antiviral agents exist. Although Dengvaxia, the only FDA-approved dengue vaccine, is licenced in 20 countries, the WHO did not recommend its use in seronegatives.